Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Tumor-cell TOP2A contributes to ochratoxin A-enhanced hepatocellular carcinoma progression and impaired CD8⁺ T-cell responses.

Ochratoxin A (OTA) is a widespread foodborne mycotoxin with hepatotoxic and immunotoxic effects, but its role in hepatocellular carcinoma (HCC) progression and antitumor immunity remains unclear. Here, we integrated network toxicology, bulk and single-cell transcriptomics, machine learning, molecular interaction assays...

Shu-Lin Li, Jie Wang, Xiao-Qin Zhai et al. · 0 citations
Review Open access Jul 2026

Protein lactylation in cancer: principles, programmes and therapeutic opportunities.

Inhibition of lactate metabolism markedly attenuates tumor-associated lactylation and exhibits substantial synergistic efficacy when combined with other anti-tumor therapies, providing an important conceptual and theoretical foundation for the development of novel cancer therapeutic strategies targeting protein lactyla...

X. Bu, Xinyue Yu, Jie Wang et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.